Patient engagement programs for recognition and initial treatment of depression in primary care: A randomized trial

JAMA

Volumn 310, Issue 17, 2013, Pages 1818-1828

  Kravitz, Richard L ^a   Franks, Peter ^a,b   Feldman, Mitchell D ^c   Tancredi, Daniel J ^a,b   Slee, Christina A ^d   Epstein, Ronald M ^e,f   Duberstein, Paul R ^e   Bell, Robert A ^a   Jackson Triche, Maga ^a   Paterniti, Debora A ^a   Cipri, Camille ^a   Iosif, Ana Maria ^a   Olson, Sarah ^c   Kelly Reif, Steven ^g   Hudnut, Andrew ^h   Dvorak, Simon ^a   Turner, Charles ^a   Jerant, Anthony ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF ROCHESTER   (United States)

^g KAISER PERMANENTE MEDICAL CENTER   (United States)

^h Sutter Medical Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DEPRESSION ENGAGEMENT VIDEO; FEMALE; GENERAL PRACTITIONER; HEALTH PROGRAM; HUMAN; INCOME; INTERACTIVE MULTIMEDIA COMPUTER PROGRAM; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEX; UNITED STATES;

EID: 84887053164     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.280038     Document Type: Article

References (47)

1. Berardi D, Menchetti M, Cevenini N, Scaini S, Versari M, De Ronchi D. Increased recognition of depression in primary care: comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom. 2005;74(4):225-230.
2. Lotfi L, Flyckt L, Krakau I, Mårtensson B, Nilsson GH. Undetected depression in primary healthcare: occurrence, severity and comorbidity in a 2-stage procedure of opportunistic screening. Nord J Psychiatry. 2010;64(6):421-427.
3. Simon GE, Fleck M, Lucas R, Bushnell DM; LIDO Group. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry. 2004;161(9):1626-1634.
4. Unützer J, Katon W, Callahan CM, et al; IMPACT Investigators: Improving Mood-Promoting Access to Collaborative Treatment. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-2845.
5. Wells KB. Caring for depression in primary care: defining and illustrating the policy context. J Clin Psychiatry. 1997;58(suppl 1):24-27.
6. Katon W, Unützer J, Wells K, Jones L. Collaborative depression care: history, evolution, and ways to enhance dissemination and sustainability. Gen Hosp Psychiatry. 2010;32(5):456-464.
7. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA. 1999;282(15):1458-1465.
8. Kravitz RL. Beyond gatekeeping: enlisting patients as agents for quality and cost-containment. J Gen Intern Med. 2008;23(10):1722-1723.
9. Bell RA, Franks P, Duberstein PR, et al. Suffering in silence: reasons for not disclosing depression in primary care. Ann Fam Med. 2011;9(5):439-446.
10. Epstein RM, Duberstein PR, Feldman MD, et al. "I didn't know what was wrong": how people with undiagnosed depression recognize, name, and explain their distress. J Gen Intern Med. 2010;25(9):954-961.
11. Kanter JW, Rusch LC, Brondino MJ. Depression self-stigma: a new measure and preliminary findings. J Nerv Ment Dis. 2008;196(9):663-670.
12. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357(7):673-681.
13. Block AE. Costs and benefits of direct-to-consumer advertising: the case of depression. Pharmacoeconomics. 2007;25(6):511-521.
14. Mintzes B, Barer ML, Kravitz RL, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? a survey in primary care environments with and without legal DTCA. CMAJ. 2003;169(5):405-412.
15. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA. 2005;293(16):1995-2002.
16. Niederdeppe J, Byrne S, Avery RJ, Cantor J. Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use. J Gen Intern Med. 2013;28(7):886-893.
17. Avery RJ, Eisenberg MD, Simon KI. The impact of direct-to-consumer television and magazine advertising on antidepressant use. J Health Econ. 2012;31(5):705-718.
18. Schmid KL, Rivers SE, Latimer AE, Salovey P. Targeting or tailoring? Mark Health Serv. 2008;28(1):32-37.
19. Jerant A, Sohler N, Fiscella K, Franks B, Franks P. Tailored interactive multimedia computer programs to reduce health disparities: opportunities and challenges. Patient Educ Couns. 2011;85(2):323-330.
20. Tancredi DJ, Slee CK, Jerant A, et al. Targeted versus tailored multimedia patient engagement to enhance depression recognition and treatment in primary care: randomized controlled trial protocol for the AMEP2 study. BMC Health Serv Res. 2013;13(1):141.
21. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135-3144.
22. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1-3):163-173.
23. Bell RA, Paterniti DA, Azari R, et al. Encouraging patients with depressive symptoms to seek care: a mixedmethods approach to message development. Patient Educ Couns. 2010;78(2):198-205.
24. Kravitz RL, Epstein RM, Bell RA, et al. An academic-marketing collaborative to promote depression care: a tale of two cultures. Patient Educ Couns. 2013;90(3):411-419.
25. Epstein A. Common Sleeping Problems [video]. HealthiNation; 2011.
26. Kravitz RL, Paterniti DA, Epstein RM, et al. Relational barriers to depression help-seeking in primary care. Patient Educ Couns. 2011;82(2):207-213.
27. Petty R, Cacioppo J. Communication and Persuasion: Central and Peripheral Routes to Attitude Change. New York, NY: Springer; 1986.
28. Dwight-Johnson M, Sherbourne CD, Liao D, Wells KB. Treatment preferences among depressed primary care patients. J Gen Intern Med. 2000;15(8):527-534.
29. Karasz A, Sacajiu G, Garcia N. Conceptual models of psychological distress among low-income patients in an inner-city primary care clinic. J Gen Intern Med. 2003;18(6):475-477.
30. Cooper-Patrick L, Powe NR, Jenckes MW, Gonzales JJ, Levine DM, Ford DE. Identification of patient attitudes and preferences regarding treatment of depression. J Gen Intern Med. 1997;12(7):431-438.
31. Dwight-Johnson M, Unutzer J, Sherbourne C, Tang L, Wells KB. Can quality improvement programs for depression in primary care address patient preferences for treatment? Med Care. 2001;39(9):934-944.
32. Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB. Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998;46(7):889-894.
33. Cooper AE, Corrigan PW, Watson AC. Mental illness stigma and care seeking. J Nerv Ment Dis. 2003;191(5):339-341.
34. Deci EL, Ryan RM. The support of autonomy and the control of behavior. J Pers Soc Psychol. 1987;53(6):1024-1037.
35. Kreuter M, Farrell D, Olevitch L, Brennan L. Tailoring Health Messages: Customizing Communication With Computer Technology. Mahwah, NJ: Erlbaum; 2000.
36. Duffy SA, Ronis DL, Valenstein M, et al A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2203-2208.
37. Ryan GL, Skinner CS, Farrell D, Champion VL. Examining the boundaries of tailoring: the utility of tailoring vs targeting mammography interventions for 2 distinct populations. Health Educ Res. 2001;16(5):555-566.
38. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
39. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):1-7. http://www.lphi.org/LPHIadmin/ uploads/.PHQ-9-Review-Kroenke-63754.PDF. Accessed October 14, 2013.
40. Wells TS, Horton JL, LeardMann CA, Jacobson IG, Boyko EJ. A comparison of the PRIME-MD PHQ-9 and PHQ-8 in a large military prospective study, the Millennium Cohort Study. J Affect Disord. 2013;148(1):77-83.
41. Fleishman JA, Selim AJ, Kazis LE. Deriving SF-12v2 physical and mental health summary scores: a comparison of different scoring algorithms. Qual Life Res. 2010;19(2):231-241.
42. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
43. Stata Statistical Software [computer program]. Version 12.1. College Station, TX: StataCorp LP; 2011.
44. Hauck WW, Anderson S, Marcus SM. Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials. 1998;19(3):249-256.
45. DeSouza CM, Legedza AT, Sankoh AJ. An overview of practical approaches for handling missing data in clinical trials. J Biopharm Stat. 2009;19(6):1055-1073.
46. MacArthur Foundation. Initiative on depression and primary care. http://www.macfound.org/networks/initiative-on-depression-primary- care/. Accessed September 27, 2013.
47. Nutting PA, Rost K, Smith J, Werner JJ, Elliot C. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med. 2000;9(10):1059-1064.